GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » Float Percentage Of Total Shares Outstanding

eFFECTOR Therapeutics (FRA:LWK) Float Percentage Of Total Shares Outstanding : 99.16% (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is eFFECTOR Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, eFFECTOR Therapeutics's float shares is 4.66 Mil. eFFECTOR Therapeutics's total shares outstanding is 4.70 Mil. eFFECTOR Therapeutics's float percentage of total shares outstanding is 99.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, eFFECTOR Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, eFFECTOR Therapeutics's Institutional Ownership is 6.05%.

eFFECTOR Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

eFFECTOR Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=4.66/4.70
=99.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

eFFECTOR Therapeutics (FRA:LWK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
CGTX VTVT PVCT PMN ELDN NERV INKT COEP PASG HOOK OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
EFTR:USA LWK:Germany
Address
142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075
Website
https://www.effector.com
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

eFFECTOR Therapeutics (FRA:LWK) Headlines

No Headlines